BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CALCB, Calcitonin
264 results:

  • 1. Expression of calcitonin Gene-Related Peptide and calcitonin Receptor-like Receptor in Colorectal Adenocarcinoma.
    Șerban RE; Stepan MD; Florescu DN; Boldeanu MV; Florescu MM; Șerbănescu MS; Ionescu M; Streba L; Drăgoescu NA; Christopher P; Obleagă VC; Constantin C; Vere CC
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674047
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
    Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
    Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH
    Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.
    Hao W; Zhao J; Guo F; Zhang J; Gu P; Ruan X; Zhang W; Zheng X; Gao M
    Clin Otolaryngol; 2023 Sep; 48(5):734-739. PubMed ID: 37366234
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
    Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
    [No Abstract]    [Full Text] [Related]  

  • 7. Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma.
    Yue W; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1025629. PubMed ID: 36506082
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation.
    Kong L; Xiong Y; Wang D; Huang L; Li M; Feng Z; Zhou Y; Zhang H; Liu F; Xiao F; Wei Y; Zhang W
    Breast Cancer Res Treat; 2022 Sep; 195(2):91-103. PubMed ID: 35896852
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Surgical selection and prognostic analysis in patients with unilateral sporadic medullary thyroid carcinoma.
    Zhang J; Gu P; Huang D; Zhao J; Zheng X; Gao M
    Langenbecks Arch Surg; 2022 Nov; 407(7):3013-3023. PubMed ID: 35748956
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
    Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
    Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. P-Glycoprotein and breast cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects.
    Bhardwaj R; Collins JL; Stringfellow J; Madonia J; Anderson MS; Finley JA; Stock DA; Coric V; Croop R; Bertz R
    Clin Pharmacol Drug Dev; 2022 Jul; 11(7):889-897. PubMed ID: 35304977
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Nerve Growth Factor in breast cancer Cells Promotes Axonal Growth and Expression of calcitonin Gene-related Peptide in a Rat Model of Spinal Metastasis.
    Mazaki AI; Yamauchi K; Orita S; Inage K; Suzuki M; Fujimoto K; Shiga Y; Abe K; Inoue M; Norimoto M; Umimura T; Ohtori S
    Anticancer Res; 2022 Jan; 42(1):581-587. PubMed ID: 34969767
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic Value of Preoperative Serum calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma.
    Park H; Park SY; Park J; Choe JH; Chung MK; Woo SY; Choi JY; Kim SW; Chung JH; Kim TH
    Front Endocrinol (Lausanne); 2021; 12():749973. PubMed ID: 34675884
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw.
    Schubert L; Russmueller G; Lagler H; Tobudic S; Heindel E; Kundi M; Steininger C
    Support Care Cancer; 2021 Dec; 29(12):7895-7902. PubMed ID: 34189608
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of cytotoxic chemotherapy on bone health among breast cancer patients. Does it require intervention?
    Nisha Y; Dubashi B; Bobby Z; Sahoo JP; Kayal S
    Support Care Cancer; 2021 Nov; 29(11):6957-6972. PubMed ID: 33954821
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.
    Zirimwabagabo JO; Jailani ABA; Avgoustou P; Tozer MJ; Gibson KR; Glossop PA; Mills JEJ; Porter RA; Blaney P; Wang N; Skerry TM; Richards GO; Harrity JPA
    J Med Chem; 2021 Mar; 64(6):3299-3319. PubMed ID: 33666424
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hereditary Medullary Thyroid Carcinoma: Genotype, Phenotype and Outcomes in a North Indian Cohort.
    Valiveru RC; Agarwal G; Agrawal V; Mayilvaganan S; Chand G; Mishra A; Agarwal A; Mishra SK; Bhatia E
    World J Surg; 2021 Jun; 45(6):1785-1793. PubMed ID: 33606078
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid Carcinoma.
    Ghazani AA; Breen KM; Dwan M; Barletta JA; Vatnick DR; Stokes SM; Block C; Doherty GM; Cohn AY; Marqusee E; Garber JE; Rana HQ
    Am J Case Rep; 2020 Dec; 21():e927415. PubMed ID: 33361738
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. breast metastasis from medullary thyroid carcinoma mimicking ductal carcinoma with neuroendocrine differentiation.
    Laforga JB; Dominguez E; Aranda FI
    Cancer Rep (Hoboken); 2020 Dec; 3(6):e1292. PubMed ID: 33025739
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.